2025 Performance Review And Future Strategy
Source: SeekingAlpha
2025-12-22 08:30:48 ET
Now that 2025 is nearing its close and the holidays are upon us, I want to wish readers a joyous year-end holiday season. You likely have festivities to attend (and I do too), but as the year winds down I wanted to close with my annual performance review. Business before pleasure, right? So let's get down to it, how did my stock picks fare in 2025? Am I due for presents under the tree this year, or just a lump of coal?...
Read the full article on Seeking Alpha
For further details see:
2025 Performance Review And Future Strategy
Syndax Pharmaceuticals Inc.
NASDAQ: SNDX
SNDX Trading
-3.25% G/L:
$23.38 Last:
835,922 Volume:
$24.24 Open:
SNDX Latest News
March 13, 2026 09:29:43 am
Cancer Drug Maker With $172 Million Revenue and Multiple Approved Therapies Draws $6.5 Million Investment
February 26, 2026 04:01:00 pm
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
SNDX Stock Data
$1,884,313,688
83,351,330
1.17%
104
N/A
Biotechnology & Life Sciences
Healthcare
US
NEW YORK
